Navigation Links
Bionovo Announces 2011 Highlights and Year-End Financial Results
Date:3/30/2012

vities of $26.0 million.  The net cash used in operating activities for 2011 was $17.6 million, compared with $14.2 million in 2010.

2012 GuidanceThe Company is providing the following guidance on key milestones for 2012:  Note that all milestones are dependent on the Company's ability to raise additional funding.Data Safety Monitoring Board interim reviews of Menerba clinical study safety data

Multiple reviews are planned during the course of the Menerba clinical studyCompletion of recruitment for 280 patients for Menerba clinical study

Completed Q1 2012Data available from 280 patients for Menerba clinical study

Anticipated by Q3 2012AboutBionovo,Inc.Bionovo, Inc. is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the OTCQB under the symbol, "BNVI ". For more information about Bionovo and its programs, visit: http://www.bionovo.com.

ForwardLookingStatementsThis release contains certain forward-looking statements relating to the business of Bionovo, Inc. that <
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
2. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
3. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
4. Bionovos Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation
5. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
6. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
7. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
8. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
9. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
10. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
11. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 2014  Decision Resources Group finds that at ... States , 54 percent of surveyed U.S. ... for BRAF -mutation-positive unresectable or metastatic melanoma, ... MEK inhibitor Mekinist. Among current non-prescribers of Tafinlar ... 43 percent, respectively) expects to prescribe these agents ...
(Date:9/18/2014)... , Sept. 18, 2014  ADM Tronics ... DeNovi , Ph.D. to its corporate Advisory Board ... an instructor at the Harvard Medical School and ... Rome.  He received his Masters degree in Electronics ... Systems from the University of Bologna. After spending a ...
(Date:9/18/2014)... Sept. 18, 2014  A $3 million grant from ... University of Michigan to establish a national center of ... Center for Aging Research at U-M will focus on ... slow the effects of aging and postpone diseases in ... that can help develop medications that may help people ...
Breaking Medicine Technology:At One Year Post-Launch, Approximately One Half of Surveyed U.S. Medical Oncologists Have Prescribed Single-Agent Tafinlar and Mekinist to Their Malignant Melanoma Patients 2ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 2ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 3$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 2$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 3
... YORK, Dec. 13, 2010 The board of directors of ... 20-cent first-quarter 2011 dividend on the company,s common stock, payable ... of business on February 4, 2011.  Pfizer increased the dividend ... per share. (Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO) "This dividend ...
... BERNARDINO, Calif., Dec. 13, 2010 Out ... nation, IEHP Medicare DualChoice (HMO SNP) is one of only five ... Part D quality and performance from the Centers for Medicare and ... to gauge how well health and drug plans perform on a ...
Cached Medicine Technology:Pfizer Declares A 20-Cent First-Quarter 2011 Dividend 2IEHP Earns Highest Rating for Medicare Part D Quality and Performance 2
(Date:9/18/2014)... Dr. David A. F. Ellis is a ... of Facial Plastic and Reconstructive Surgery and a Professor ... Facial Plastic Surgery. He is recognized around the ... , Dr. Ellis will be presenting on numerous injectable ... injection techniques and various treatments for complications associated with ...
(Date:9/18/2014)... News) -- Rising temperatures in the Atlantic Ocean may ... waters that are becoming warmer, an expansion that could ... A study of 40 species along the reefs ... the invasive and poisonous lionfish, according to researchers from ... University of North Carolina-Wilmington, who published their findings in ...
(Date:9/18/2014)... Obispo, CA (PRWEB) September 18, 2014 It’s ... introduced their newest, patent pending bunion splint to website ... one loyalist, Rosa, wrote: "I was absolutely delighted. It is ... honestly forget I am wearing them. THANK YOU FOR LISTENING!!!" ... introduced design by saying, "The hole used to slip to ...
(Date:9/18/2014)... HealthDay Reporter , THURSDAY, Sept. 18, 2014 ... antidepressant can quickly alter the way brain cells communicate with ... Sept. 18 in Current Biology , are a ... antidepressants. Experts said the hope is to eventually be able ... from a drug -- and which people would fare better ...
(Date:9/18/2014)... TayganPoint Consulting Group, a leading strategic ... co-founder John Cassimatis was named as one of ... recognizing the region’s top healthcare and life science ... the year. , The Innovation Awards celebrate companies ... to shape the medical industry in Greater Philadelphia ...
Breaking Medicine News(10 mins):Health News:Dr. David A. F. Ellis Has Been Invited to Speak at a Conference of the American Academy of Facial Plastic and Reconstructive Surgery in Orlando, Florida 2Health News:Rising Atlantic Ocean Temperatures Could Pose Threat to Reefs 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 3Health News:One Dose of Antidepressant Changes Brain Connections, Study Says 2Health News:One Dose of Antidepressant Changes Brain Connections, Study Says 3Health News:TayganPoint Executive Receives Prestigious Award from Philadelphia Business Journal 2
... At 8,500 a piece it doesnt come cheap. But the new bionic ... previous artificial limbs . , ,It can't click its ... do. , ,It can, for instance, turn a key ... into a cash machine. , ,David Gow who works with ...
... non-pyrethroid insecticide, propoxur, and a repellent, N,N-diethyl toluamide ... synergy against mosquitoes responsible for malaria transmission to ... had proved to be much more effective than ... nets soaked with this mixture had a lethal ...
... a 10 million dollar specialist cancer hospital which will enable ... . ,Mwanawasa said the National Cancer Diseases Hospital ... cancer patients in Zambia who have previously had to be ... average 10,000 dollars per person. ,"Treatment at the ...
... in collaboration with the U.K.-based Oxford Brookes University, has ... . ,For the people of the city ... a significant development. For now scientific testing methodology is ... speed at which food is converted into blood glucose) ...
... been registered against the premier institute of medicine AIIMS and ... lakhs by the State Consumer Commission . ,All India ... a woman as cancer patient and removing her breast as ... Commission Bench headed by Justice J D Kapoor held the ...
... sensible diet, exercise and weight control helps people live ... Hughes Medical Institute have found that all these factors ... in the brain. ,This insulin-like pathway governs ... The pathway is activated when insulin and insulin-like growth ...
Cached Medicine News:Health News:Scottish Engineer Devises Versatile Hand 2Health News:Insecticide and Repellent Combo Effective in Eliminating Malarial Mosquitoes 2Health News:A Centre for Glycemic Index Testing Opened in Chennai 2Health News:AIIMS Fined Rs 5 Lakhs for Negligence 2Health News:Sensible Diet, Exercise and Weight Control Increases Longevity 2Health News:Sensible Diet, Exercise and Weight Control Increases Longevity 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: